Ro Khanna sold Elevance Health Inc (NYSE: ELV)
Ro Khanna sold ELV · disclosed December 8, 2025
Ro Khanna, a CA House member representing District 17, sold $1,001 - $15,000 of Elevance Health Inc (ELV) on November 3, 2025. Filings associated with Ro Khanna disclosed 14 other ELV transactions (6 purchases and 8 sales) in the 12 months before this trade. Shares of ELV have fallen 8.8% since the first observed purchase on March 24, 2023. The filing was publicly disclosed on December 8, 2025; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Ro Khanna's complete filing history, visit Ro Khanna's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on ELV break down as 0 strong buy, 14 buy, 6 hold, 0 sell, 0 strong sell.
- ELV carries a Risk Score of 95 as of September 9, 2026. On this scale, a higher score means a lower risk surface.
- Ro Khanna sold ELV in the amount range of $1,001 - $15,000 on November 3, 2025, filed under the STOCK Act.
- The filing lists Dependent child as the transaction owner and was disclosed 35 days after the trade.
- The asset description in the filing reads 'ELEVANCE HEALTH INC (CMN).'
- Filings associated with Ro Khanna disclosed 14 other ELV transactions (6 purchases and 8 sales) in the 12 months before this trade.
- Shares of ELV have fallen 8.8% since the first observed purchase on March 24, 2023.
- ELV carried a Q Score of 71.9 in its equity peer group as of September 8, 2026.
- ELV carried a Squeeze Score of 21 as of September 10, 2026.
Did Ro Khanna buy or sell ELV?
The Periodic Transaction Report covers a single sale involving ELV on November 3, 2025. The filed amount range is $1,001 - $15,000. The asset description reads 'ELEVANCE HEALTH INC (CMN)', as submitted by the filer. The report was submitted on December 8, 2025. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Ro Khanna (House) | Sell | ELV | $1,001 - $15,000 | November 3, 2025 | December 8, 2025 |
What other ELV trades has Ro Khanna disclosed in the past 12 months?
Filings associated with Ro Khanna disclosed 14 other ELV transactions (6 purchases and 8 sales) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| September 29, 2025 | Sell | Dependent child | $1,001 - $15,000 | Filing unavailable |
| September 5, 2025 | Sell | Dependent child | $1,001 - $15,000 | Filing unavailable |
| September 5, 2025 | Sell | Spouse | $15,001 - $50,000 | Filing unavailable |
| August 26, 2025 | Buy | Dependent child | $1,001 - $15,000 | Filing unavailable |
| August 4, 2025 | Buy | Spouse | $1,001 - $15,000 | Filing unavailable |
| July 25, 2025 | Buy | Dependent child | $15,001 - $50,000 | Filing unavailable |
| May 28, 2025 | Sell | Spouse | $1,001 - $15,000 | Filing unavailable |
| May 19, 2025 | Sell | Dependent child | $1,001 - $15,000 | Filing unavailable |
| March 12, 2025 | Buy | Spouse | $1,001 - $15,000 | Filing unavailable |
| December 18, 2024 | Buy | Dependent child | $1,001 - $15,000 | Filing unavailable |
| December 16, 2024 | Buy | Spouse | $15,001 - $50,000 | Filing unavailable |
| November 26, 2024 | Sell | Spouse | $1,001 - $15,000 | Filing unavailable |
| November 15, 2024 | Sell | Dependent child | $1,001 - $15,000 | Filing unavailable |
| November 12, 2024 | Sell | Spouse | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a sale involving ELV by Ro Khanna in the amount range of $1,001 - $15,000, with Dependent child listed as the owner. It does not establish Ro Khanna's total holdings in ELV, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'ELEVANCE HEALTH INC (CMN)', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Ro Khanna's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Ro Khanna disclosed 14 other ELV transactions (6 purchases and 8 sales) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded ELV?
Quantellect's current database lists these recent ELV disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Alan Armstrong Self | R Senate | Buy | $1,001 - $15,000 | July 21, 2026Filing unavailable |
| Markwayne Mullin Joint | R Senate | Buy | $15,001 - $50,000 | January 16, 2026Filing unavailable |
| Michael T. McCaul Spouse | R House | Sell | $15,001 - $50,000 | November 10, 2025Filing unavailable |
How has Ro Khanna's disclosed trading performed?
Ro Khanna holds a Quantellect Q Score of 90 (elite), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #9 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Ro Khanna ELV trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Ro Khanna buy or sell ELV?
According to the disclosure, Ro Khanna sold ELV on November 3, 2025.
What amount was reported for the ELV transaction?
The disclosure reports $1,001 - $15,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated November 3, 2025, and it was disclosed on December 8, 2025.
Where can I see Ro Khanna's other congressional trades?
Quantellect lists Ro Khanna's complete disclosed trade history on the member profile. Ro Khanna's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.